Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

129.9 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Omzet 131.314196.245277.133186.419120.282251.453141.102108.97371.91464.53848.97431.38830.03723.53838.9427.31512.894140.96176.608163.512141.1496.6476.34148.1140.917.751.736.824.513.3
Kosten van de omzet 11.56152.82762.17630.41911.3476.3375.3665.5715.8079.1365.7333.6014.909015.2350022.64239.84739.80431.61820.30613.9471.6183.1-7.7-9.8-9.4-3.724.7
Brutowinst 119.753143.418214.957156108.935245.116135.736103.40266.10755.40243.24127.78725.12823.53823.70527.31512.894118.318136.761123.708109.52276.33462.39446.49237.825.461.546.228.2-11.4
Brutowinstmarge 0.9120.7310.7760.8370.9060.9750.9620.9490.9190.8580.8830.8850.83710.609110.8390.7740.7570.7760.790.8170.9660.9241.4351.191.2551.151-0.857
Onderzoek- en ontwikkelingskosten 24.53736.08269.01259.39255.90827.86326.88721.22113.3812.1229.27410.7910.29122.06739.8730.7744.62341.92656.07565.20467.67958.80751.10451.28759.470.772.459.541.40
Algemene en administratieve kosten 52.7970.06257.48364.43541.88437.73428.65326.62124.37822.5717.98416.10814.97729.72330.44623.78530.41248.281107.15795.87561.02141.67834.42734.11427.316.610.110.200
Verkoop- en marketingkosten 00000000000000-15.235000000000000000
Verkoop-, algemene en administratieve kosten 52.7970.06257.48364.43541.88437.73428.65326.62124.37822.5717.98416.10814.97729.72315.21123.78530.41248.281107.15795.87561.02141.67834.42734.11427.316.610.110.287
Overige kosten -32.60534.2379.56723.44216.86415.79212.1210.643-10.034-3.189-2.139-2.789000-1.964-1.964-3.11978.04962.0350.53116.68906.9737.47.79.89.43.72.5
Bedrijfskosten 109.932140.381136.062147.269114.65681.38967.6658.48537.75834.69227.25826.89825.26851.7970.31652.59173.069287.088163.232161.079128.7100.48585.53192.37494.19592.379.153.19.5
Bedrijfsresultaat 9.821-25.50378.8958.55-5.721163.72768.07643.88527.32919.62614.9430.574-0.698-29.304-9.967-97.276-60.175-168.77-26.471-37.371-19.178-24.151-23.137-45.882-56.3-69.6-30.8-32.9-24.9-20.9
Bedrijfsresultaat ratio 0.075-0.130.2850.046-0.0480.6510.4820.4030.380.3040.3050.018-0.023-1.245-0.256-3.561-4.667-1.197-0.15-0.229-0.136-0.25-0.303-0.954-1.377-3.932-0.596-0.894-1.016-1.571
Totaal overige inkomsten en kosten netto 53.83961.514-31.597-19.088802.3643.88-10.845-36.9576.98-9.408-6.776-4.754-0.0511.147-0.347-72.2340.7634.4511.22615.54-6.092-3.236-8.363-0.825-5.7-43-61.33.7-33.8-5.5
Inkomen voor belasting 63.6636.01147.298-10.538796.639173.3357.2317.9635.32911.3029.207-3.865-2.93-15.403-9.872-97.515-53.456-174.27336.34-44.908-37.462-32.596-31.5-46.707-62-112.6-92.1-29.2-58.7-26.4
Inkomen voor belasting ratio 0.4850.1840.171-0.0576.6230.6890.4060.0730.4910.1750.188-0.123-0.098-0.654-0.254-3.57-4.146-1.2360.206-0.275-0.265-0.337-0.413-0.971-1.516-6.362-1.781-0.793-2.396-1.985
Belastingkosten 9.84141.23-10.288-7.553167.33730.00944.67510.327-219.5960.410.374-1.191-13.103-2.617-7.924-0.055-18.697-38.4140.0590.23318.2848.44519.85826.49418.448.369.44.439.36.2
Nettowinst 52.154-5.21957.138-2.985629.302143.32112.556-1.636257.30512.02411.421-0.52710.176-12.515-1.948-98.114281.688-31.743-36.399-45.141-37.462-32.596-42.995-72.376-74.7-117.9-100.2-37.3-64.2-27.1
Nettowinstmarge 0.397-0.0270.206-0.0165.2320.570.089-0.0153.5780.1860.233-0.0170.339-0.532-0.05-3.59221.846-0.225-0.206-0.276-0.265-0.337-0.563-1.504-1.826-6.661-1.938-1.014-2.62-2.038
WPA (Winst Per Aandeel) 3.02-0.313.44-0.1833.135.960.6-0.079130.590.56-0.0280.52-0.64-0.1-6.1617.22-2.36-2.95-3.68-3.18-2.83-4.34-7.8-9.51-17.51-18.15-7.78-17.19-9.42
Verwaterde WPA 2.94-0.313.31-0.1831.855.960.53-0.07912.120.560.55-0.0270.52-0.64-0.1-6.1617.22-2.36-2.95-3.68-3.18-2.83-4.34-7.8-9.51-17.51-18.15-7.78-17.19-9.42
EBITDA 51.2238.734117.20231.992-804.542179.51982.77659.9266.19226.92920.622.854-1.77-37.697-31.02948.01-58.323-157.003-18.99-37.6361.194-10.443-8.201-38.084-43.2-18.940.3-27.212.6-12.9
EBITDA ratio 0.390.0450.4230.172-6.6890.7140.5870.550.0860.4170.4210.091-0.059-1.602-0.7971.758-4.523-1.114-0.108-0.230.008-0.108-0.107-0.792-1.056-1.0680.779-0.7390.514-0.97